In a head-to-head comparison of octreotide and pasireotide in a rat model of spontaneous nonfunctioning pituitary adenoma, pasireotide showed a superior antitumor effect compared to octreotide, particularly in female rats, which also expressed more SSTR3 than males [18]. Here, SSTR3 is linked to pituitary gland adenoma.